Literature DB >> 1653539

Time course of endothelial dysfunction and myocardial injury during coronary arterial occlusion.

G E Viehman1, X L Ma, D J Lefer, A M Lefer.   

Abstract

The time course of the effects of permanent myocardial ischemia without reperfusion on the coronary vascular endothelium and myocardium were investigated in anesthetized cats. The left anterior descending (LAD) coronary artery was occluded for 1.5, 3.0, 4.5, or 6.0 h. Coronary rings from the ischemic LAD and the nonischemic left circumflex (LCX) arteries were tested for their responsiveness to the endothelium-dependent vasodilators acetylcholine (ACh, 0.1-100 nM) and the calcium ionophore A23187 (1-1,000 nM), and the endothelium-independent vasodilator sodium nitrite (NaNO2, 0.1-100 microM). Vasorelaxation was not significantly impaired in response to ACh after 1.5 h of ischemia and only moderately impaired after 3.0 h of ischemia (63 +/- 5% of control). However, after 4.5 h of ischemia the ACh-induced response was decreased to 33 +/- 4% of control and further declined to 31 +/- 4% of control after 6.0 h (P less than 0.001 from 1.5 h). There was no significant decrease in LCX ring vasorelaxant responses to vasodilators at all times, and the LAD rings only showed a moderately decreased response to NaNO2 after 6.0 h of ischemia (82 +/- 4% relaxation, P less than 0.05). Transmission electron microscopy revealed very little endothelial damage at 4.5 and 6.0 h, with only some subendothelial swelling noted. Damage to the myocardium did not become significant until after 4.5 h of ischemia, and cardiac myeloperoxidase activity, indicative of neutrophil accumulation, was not significant at any time.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653539     DOI: 10.1152/ajpheart.1991.261.3.H874

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Endothelial Dysfunction as a Trigger for Ischemia-Reperfusion Injury.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

Review 2.  The paradox of the neutrophil's role in tissue injury.

Authors:  George B Segel; Marc W Halterman; Marshall A Lichtman
Journal:  J Leukoc Biol       Date:  2010-11-19       Impact factor: 4.962

3.  Optimal Duration of Coronary Ligation and Reperfusion for Reperfusion Injury Study in a Rat Model.

Authors:  Shih-Tai Chang; Chi-Ming Chu; Teng-Yao Yang; Li-Man Hung; Kuo-Li Pan; Wen-Jin Cherng
Journal:  Acta Cardiol Sin       Date:  2016-07       Impact factor: 2.672

Review 4.  Intramyocardial haemorrhage after acute myocardial infarction.

Authors:  Ryanne P Betgem; Guus A de Waard; Robin Nijveldt; Aernout M Beek; Javier Escaned; Niels van Royen
Journal:  Nat Rev Cardiol       Date:  2014-11-18       Impact factor: 32.419

5.  Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion.

Authors:  X L Ma; P S Tsao; A M Lefer
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

Review 6.  Nitric oxide and cardioprotection during ischemia-reperfusion.

Authors:  Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

7.  Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats.

Authors:  M Buerke; A S Weyrich; Z Zheng; F C Gaeta; M J Forrest; A M Lefer
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

8.  Role of Endothelial Cells in Myocardial Ischemia-Reperfusion Injury.

Authors:  Arun K Singhal; J David Symons; Sihem Boudina; Bharat Jaishy; Yan-Ting Shiu
Journal:  Vasc Dis Prev       Date:  2010

9.  Redefining successful primary PCI.

Authors:  Peter J McCartney; Colin Berry
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-02-01       Impact factor: 6.875

10.  Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction.

Authors:  Lara S F Konijnenberg; Peter Damman; Dirk J Duncker; Robert A Kloner; Robin Nijveldt; Robert-Jan M van Geuns; Colin Berry; Niels P Riksen; Javier Escaned; Niels van Royen
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.